Detalhe da pesquisa
1.
Choosing profile double-sampling designs for survival estimation with application to President's Emergency Plan for AIDS Relief evaluation.
Stat Med
; 33(12): 2017-29, 2014 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24408038
2.
Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials.
Contemp Clin Trials Commun
; 23: 100827, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430754
3.
Principles of Good Clinical Trial Design.
J Thorac Oncol
; 15(8): 1277-1280, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417343
4.
Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials.
Contemp Clin Trials Commun
; 17: 100492, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872158
5.
Longitudinal evaluation of sleep-disordered breathing and sleep symptoms with change in quality of life: the Sleep Heart Health Study (SHHS).
Sleep
; 32(8): 1049-57, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19725256
6.
The need for double-sampling designs in survival studies: an application to monitor PEPFAR.
Biometrics
; 65(1): 301-6, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18479488
7.
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32190807
8.
Flexible Random Intercept Models for Binary Outcomes Using Mixtures of Normals.
Comput Stat Data Anal
; 51(11): 5220-5235, 2007 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18628822
9.
Precision oncology: A new era of cancer clinical trials.
Cancer Lett
; 387: 121-126, 2017 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26987624
10.
Clinical trial designs incorporating predictive biomarkers.
Cancer Treat Rev
; 43: 74-82, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26827695
11.
Reopening Colleges During the Coronavirus Disease 2019 (COVID-19) Pandemic-One Size Does Not Fit All.
JAMA Netw Open
; 3(7): e2017838, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735333
12.
Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter.
Biol Direct
; 10: 15, 2015 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887039
13.
The direct assignment option as a modular design component: an example for the setting of two predefined subgroups.
Comput Math Methods Med
; 2015: 210817, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25649690
14.
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.
J Clin Oncol
; 33(34): 4048-57, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503199
15.
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.
J Natl Cancer Inst
; 107(11)2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26296640
16.
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignment.
Contemp Clin Trials
; 38(2): 157-62, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768938
17.
Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouse.
J Clin Oncol
; 32(8): 841-50, 2014 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24516033
18.
A review of phase II trial designs for initial marker validation.
Contemp Clin Trials
; 36(2): 597-604, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23665336
19.
A 2-stage phase II design with direct assignment option in stage II for initial marker validation.
Clin Cancer Res
; 18(16): 4225-33, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22700865
20.
Time to progression ratio: promising new metric or just another metric?
Ann Transl Med
; 4(Suppl 1): S43, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27868011